Zeng Guang-Gui, Jiang Wan-Li, Yu Jiang, Nie Gui-Ying, Lu Yu-Ru, Xiao Chang-Kai, Wang Chuan, Zheng Kang
Department of Clinical Laboratory, Hengyang Central Hospital, Hengyang, Hunan, China; Institute of Pathogenic Biology, Hengyang Medical College, University of South China, Hengyang, Hunan, China; Institute of Cardiovascular Disease, Key Laboratory for Arteriosclerology of Hunan Province, 2020 Grade Excellent Doctor Class of Hengyang Medical College, University of South China, Hengyang, Hunan, China.
Institute of Cardiovascular Disease, Key Laboratory for Arteriosclerology of Hunan Province, 2020 Grade Excellent Doctor Class of Hengyang Medical College, University of South China, Hengyang, Hunan, China.
Curr Probl Cardiol. 2024 Jan;49(1 Pt C):102116. doi: 10.1016/j.cpcardiol.2023.102116. Epub 2023 Oct 5.
Mpox, a novel epidemic disease, has broken out the period of coronavirus disease 2019 since May 2022, which was caused by the mpox virus. Up to 12 September 2023, there are more than 90,439 confirmed mpox cases in over 115 countries all over the world. Moreover, the outbreak of mpox in 2022 was verified to be Clade II rather than Clade I. Highlighting the significance of this finding, a growing body of literature suggests that mpox may lead to a series of cardiovascular complications, including myocarditis and pericarditis. It is indeed crucial to acquire more knowledge about mpox from a perspective from the clinical cardiologist. In this review, we would discuss the epidemiological characteristics and primary treatments of mpox to attempt to provide a framework for cardiovascular physicians.
猴痘是一种新型传染病,自2022年5月以来在2019冠状病毒病流行期间爆发,由猴痘病毒引起。截至2023年9月12日,全球115多个国家有超过90439例猴痘确诊病例。此外,2022年的猴痘疫情经证实为II型分支而非I型分支。越来越多的文献表明猴痘可能导致一系列心血管并发症,包括心肌炎和心包炎,这凸显了这一发现的重要性。从临床心脏病专家的角度获取更多关于猴痘的知识确实至关重要。在这篇综述中,我们将讨论猴痘的流行病学特征和主要治疗方法,试图为心血管内科医生提供一个框架。